David M. Ritter

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

18h-index1.5kcitations93works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberous Sclerosis Complex Research(17), Boron Compounds in Chemistry(14), Organoboron and organosilicon chemistry(11), Ion channel regulation and function(9), Electrochemical Analysis and Applications(9)

Publications93 total

Limited Utility for Head Ultrasounds in the Evaluation of Tuberous Sclerosis Complex
Pediatric Neurology·2025Open Access
Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma‐Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis Complex
American Journal of Medical Genetics Part A·2025· 1 citedOpen Access
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis
Pediatric Neurology·2025· 2 cited
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature
Expert Review of Neurotherapeutics·2025· 3 cited
Survey of Reproductive Health in Women with Tuberous Sclerosis Complex Suggests a Risk for Preeclampsia
North American Proceedings in Gynecology and Obstetrics - Supplemental·2025Open Access
Altered cortical excitability in tuberous sclerosis and the effect of mTOR inhibitors: An intracranial electrical stimulation study
Clinical Neurophysiology·2025
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results
UNC Libraries·2024Open Access
Cenobamate's Efficacy for Seizure Treatment in Tuberous Sclerosis Complex
Pediatric Neurology·2024· 9 cited
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment
Pediatric Neurology·2024· 4 cited
Impact of Race in Missed Appointments in Pediatric Neurology Resident Clinic at a Large Tertiary Medical Center
Journal of Child Neurology·2024· 1 cited
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results
Annals of the Child Neurology Society·2024· 10 citedOpen Access
CARDIAC RHABDOMYOMAS IN TUBEROUS SCLEROSIS: IMPACT OF MTOR INHIBITORS ON PROGRESSION AND ASSOCIATION WITH OTHER MEDICAL COMORBIDITIES
Journal of the American College of Cardiology·2024
Exploring the neurological features of individuals with germline <scp>PTEN</scp> variants: A multicenter study
Annals of Clinical and Translational Neurology·2024· 9 citedOpen Access
Healthcare provider recognition of pregnancy related risks and management considerations in patients with tuberous sclerosis complex
Orphanet Journal of Rare Diseases·2024· 4 citedOpen Access
Long-Term Efficacy and Safety of mTOR-Inhibitor Treatmentfor Subependymalgiant-Cellastrocytomain Tuberous Sclerosis
SSRN Electronic Journal·2024Open Access
Cenobamate's Efficacy for Seizure Treatment in Patients with Tuberous Sclerosis Complex
SSRN Electronic Journal·2024Open Access
P233: PKD1 hypomorphic variant in a girl with tuberous sclerosis complex and polycystic kidneys
Genetics in Medicine Open·2024Open Access
Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female Mice
eNeuro·2023· 6 citedOpen Access
Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex
Orphanet Journal of Rare Diseases·2022· 8 citedOpen Access
Acute Ataxia and Paresthesia in a Healthy 5-year-old Girl
Pediatrics in Review·2021
page 1 of 5Next →

Frequent Co-authors

Manuel Covarrubias(5), H. I. Schlesinger(4), James C. Weisshaar(4), Derrol Pennington(4), James C. M. Li(4), William R. Deever(4), David Neal Franz(4), Darcy A. Krueger(4), Benjamin M. Zemel(3), Earl R. Lory(3), Herbert C. Brown(2), I. Sheft(2), Michael E. O’Leary(2), Angelo C. Lepore(2), Anton B. Burg(2), Jamie K. Capal(2), Paul S. Horn(2), Gilbert R. Seely(2), B. Abraham(1), A. C. Bond(1)